SC 13G

Company

Edesa Biotech, Inc.

Filed

May 15, 2018

Accession Number

0001193125-18-164065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →